<DOC>
	<DOCNO>NCT02641652</DOCNO>
	<brief_summary>There currently establish treatment paroxysmal hypertension , selective serotonin reuptake inhibitor show good effect previous report . This double-blind , placebo control , prospective multicenter clinical trial ass efficacy sertraline cessation reduction symptom paroxysmal arterial hypertension . 136 patient document hypertensive paroxysm abrupt elevation blood pressure distressful physical symptom randomize 1:1 ratio receive sertraline , 50 mg daily , match placebo add-on chronic medication . Effect treatment patient symptom , office ambulatory blood pressure side effect evaluate 3 month . If proven effective , sertraline might become standard treatment condition .</brief_summary>
	<brief_title>A Randomized Controlled Trial Sertraline Paroxysmal Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Study enroll adult patient ( age &gt; 18 year ) hypertensive paroxysm past 6 month ( preferably past 6 week ) abrupt elevation systolic blood pressure ( BP ) ≥20 % compare previous measure systolic BP value paroxysm , ≥20 % compare mean systolic BP 24hour ambulatory blood pressure monitoring ( ABPM ) , ≥20 % compare measured office systolic BP , document clinician home blood pressure monitor , require physician emergency room visit use rescue antihypertensive medication . Hypertensive paroxysm may accompany abrupt onset one distressful physical symptom , headache , chest pain , dizziness , nausea , palpitation , flushing , diaphoresis . Pregnancy breastfeeding , hypersensitivity sertraline ( Zoloft® ) component drug . Current use sertraline selective serotonin reuptake inhibitor ( SSRI ) , monoamin oxidase ( MAO ) inhibitor , selegiline , moclobemide , linezolide , pimozide . Current use serotoninergic drug ( eg . tryptofane , triptane 5HT agonist ) , tramadol dopamine antagonist ( include antipsychotic ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>paroxysmal hypertension</keyword>
	<keyword>pseudopheochromocytoma</keyword>
</DOC>